• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Lipid-derived electrophiles mediate the effects of chemotherapeutic topoisomerase I poisons.脂质衍生的亲电试剂介导化疗拓扑异构酶 I 毒物的作用。
Cell Chem Biol. 2021 Jun 17;28(6):776-787.e8. doi: 10.1016/j.chembiol.2020.11.011. Epub 2020 Dec 21.
2
Poly(ADP-ribose) polymers regulate DNA topoisomerase I (Top1) nuclear dynamics and camptothecin sensitivity in living cells.聚(ADP - 核糖)聚合物调节活细胞中DNA拓扑异构酶I(Top1)的核动力学和喜树碱敏感性。
Nucleic Acids Res. 2016 Sep 30;44(17):8363-75. doi: 10.1093/nar/gkw665. Epub 2016 Jul 27.
3
Trapping of mammalian topoisomerase I and recombinations induced by damaged DNA containing nicks or gaps. Importance of DNA end phosphorylation and camptothecin effects.哺乳动物拓扑异构酶I的捕获以及由含切口或缺口的受损DNA诱导的重组。DNA末端磷酸化的重要性及喜树碱的作用
J Biol Chem. 1997 Oct 17;272(42):26441-7. doi: 10.1074/jbc.272.42.26441.
4
Topoisomerase I activity and sensitivity to camptothecin in breast cancer-derived cells: a comparative study.拓扑异构酶 I 活性和对喜树碱的敏感性在乳腺癌衍生细胞中的比较研究。
BMC Cancer. 2019 Nov 29;19(1):1158. doi: 10.1186/s12885-019-6371-0.
5
Tyrosyl-DNA phosphodiesterase 2 (TDP2) repairs topoisomerase 1 DNA-protein crosslinks and 3'-blocking lesions in the absence of tyrosyl-DNA phosphodiesterase 1 (TDP1).酪氨酰 DNA 磷酸二酯酶 2(TDP2)在缺乏酪氨酰 DNA 磷酸二酯酶 1(TDP1)的情况下修复拓扑异构酶 1 DNA-蛋白质交联物和 3'-阻断损伤。
DNA Repair (Amst). 2020 Jul-Aug;91-92:102849. doi: 10.1016/j.dnarep.2020.102849. Epub 2020 May 17.
6
A camptothecin-resistant DNA topoisomerase I mutant exhibits altered sensitivities to other DNA topoisomerase poisons.一种喜树碱抗性DNA拓扑异构酶I突变体对其他DNA拓扑异构酶毒物表现出不同的敏感性。
J Biol Chem. 1995 Mar 17;270(11):6141-8. doi: 10.1074/jbc.270.11.6141.
7
Mechanisms of resistance to topoisomerase I-targeting drugs.对靶向拓扑异构酶I药物的耐药机制。
Oncogene. 2003 Oct 20;22(47):7296-304. doi: 10.1038/sj.onc.1206935.
8
Genome-destabilizing effects associated with top1 loss or accumulation of top1 cleavage complexes in yeast.酵母中与拓扑异构酶1(Top1)缺失或Top1切割复合物积累相关的基因组不稳定效应。
PLoS Genet. 2015 Apr 1;11(4):e1005098. doi: 10.1371/journal.pgen.1005098. eCollection 2015 Apr.
9
Topoisomerase I requirement for death receptor-induced apoptotic nuclear fission.死亡受体诱导的凋亡性核裂变对拓扑异构酶I的需求。
J Biol Chem. 2008 Aug 22;283(34):23200-8. doi: 10.1074/jbc.M801146200. Epub 2008 Jun 13.
10
Interaction of an alkylating camptothecin derivative with a DNA base at topoisomerase I-DNA cleavage sites.一种烷基化喜树碱衍生物与拓扑异构酶I-DNA切割位点处的DNA碱基的相互作用。
Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8861-5. doi: 10.1073/pnas.92.19.8861.

引用本文的文献

1
Cellular senescence in colorectal cancer: its occurrence, effect and therapy.结直肠癌中的细胞衰老:其发生、影响及治疗
Front Oncol. 2025 Aug 15;15:1580951. doi: 10.3389/fonc.2025.1580951. eCollection 2025.
2
The Peroxidation of Lipids, Cellular Senescence and Aging.脂质过氧化、细胞衰老与老化
J Aging Sci. 2024;12(4). Epub 2024 Dec 2.
3
Aldehyde-induced DNA-protein crosslinks- DNA damage, repair and mutagenesis.醛诱导的DNA-蛋白质交联——DNA损伤、修复与诱变
Front Oncol. 2024 Sep 12;14:1478373. doi: 10.3389/fonc.2024.1478373. eCollection 2024.
4
MLLT11 Regulates Endometrial Stroma Cell Adhesion, Proliferation and Survival in Ectopic Lesions of Women with Advanced Endometriosis.MLLT11 调控子宫内膜异位症患者在位内膜间质细胞黏附、增殖和存活。
Int J Mol Sci. 2023 Dec 28;25(1):439. doi: 10.3390/ijms25010439.
5
Isolation and detection of DNA-protein crosslinks in mammalian cells.哺乳动物细胞中 DNA-蛋白质交联的分离与检测。
Nucleic Acids Res. 2024 Jan 25;52(2):525-547. doi: 10.1093/nar/gkad1178.
6
Getting stressed over topoisomerase I poisons.纠结于拓扑异构酶 I 抑制剂。
Cell Chem Biol. 2021 Jun 17;28(6):743-745. doi: 10.1016/j.chembiol.2021.04.015.

本文引用的文献

1
Elucidation of Mechanisms of Topotecan-Induced Cell Death in Human Breast MCF-7 Cancer Cells by Gene Expression Analysis.通过基因表达分析阐明拓扑替康诱导人乳腺癌MCF-7细胞死亡的机制
Front Genet. 2020 Jul 17;11:775. doi: 10.3389/fgene.2020.00775. eCollection 2020.
2
Targeting Topoisomerase I in the Era of Precision Medicine.靶向精准医学时代的拓扑异构酶 I。
Clin Cancer Res. 2019 Nov 15;25(22):6581-6589. doi: 10.1158/1078-0432.CCR-19-1089. Epub 2019 Jun 21.
3
Aldehyde oxidase and its role as a drug metabolizing enzyme.醛氧化酶及其作为药物代谢酶的作用。
Pharmacol Ther. 2019 Sep;201:137-180. doi: 10.1016/j.pharmthera.2019.05.011. Epub 2019 May 24.
4
A comprehensive review of topoisomerase inhibitors as anticancer agents in the past decade.近十年拓扑异构酶抑制剂作为抗癌药物的全面综述。
Eur J Med Chem. 2019 Jun 1;171:129-168. doi: 10.1016/j.ejmech.2019.03.034. Epub 2019 Mar 20.
5
Topoisomerase 1B poisons: Over a half-century of drug leads, clinical candidates, and serendipitous discoveries.拓扑异构酶 1B 抑制剂:半个多世纪的药物先导物、临床候选药物和偶然发现。
Med Res Rev. 2019 Jul;39(4):1294-1337. doi: 10.1002/med.21546. Epub 2018 Nov 19.
6
Structural and mechanistic aspects of S-S bonds in the thioredoxin-like family of proteins.硫氧还蛋白样蛋白家族中 S-S 键的结构和机制方面。
Biol Chem. 2019 Apr 24;400(5):575-587. doi: 10.1515/hsz-2018-0319.
7
Camptothecin Efficacy to Poison Top1 Is Altered by Bisphenol A in Mouse Embryonic Fibroblasts.双酚 A 改变喜树碱对 Top1 的抑制效果。
Chem Res Toxicol. 2018 Jun 18;31(6):510-519. doi: 10.1021/acs.chemrestox.8b00050. Epub 2018 Jun 5.
8
Topoisomerases as anticancer targets.拓扑异构酶作为抗癌靶点。
Biochem J. 2018 Jan 23;475(2):373-398. doi: 10.1042/BCJ20160583.
9
Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?喜树碱(CPT)及其衍生物已知以拓扑异构酶I(Top1)为作用靶点:在用于治疗癌症等人类疾病的喜树碱类似物分子靶点方面,我们是否遗漏了什么?
Am J Cancer Res. 2017 Dec 1;7(12):2350-2394. eCollection 2017.
10
Induction of oxidative stress by anticancer drugs in the presence and absence of cells.在有细胞和无细胞的情况下抗癌药物诱导氧化应激。
Oncol Lett. 2017 Nov;14(5):6066-6070. doi: 10.3892/ol.2017.6931. Epub 2017 Sep 14.

脂质衍生的亲电试剂介导化疗拓扑异构酶 I 毒物的作用。

Lipid-derived electrophiles mediate the effects of chemotherapeutic topoisomerase I poisons.

机构信息

University of Chicago, Department of Molecular Genetics and Cell Biology, 929 E. 57th Street W522A, Chicago, IL 60637, USA.

University of Illinois Chicago, College of Pharmacy, Department of Pharmaceutical Sciences, Rockford, IL 61107, USA.

出版信息

Cell Chem Biol. 2021 Jun 17;28(6):776-787.e8. doi: 10.1016/j.chembiol.2020.11.011. Epub 2020 Dec 21.

DOI:10.1016/j.chembiol.2020.11.011
PMID:33352117
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8206239/
Abstract

Topoisomerase 1 (Top1) reversibly nicks chromosomal DNA to relax strain accumulated during transcription, replication, chromatin assembly, and chromosome condensation. The Top1 poison camptothecin targets cancer cells by trapping the enzyme in the covalent complex Top1, tethered to cleaved DNA by a tyrosine-3'-phosphate bond. In vitro mechanistic studies point to interfacial inhibition, where camptothecin binding to the Top1-DNA interface stabilizes Top1. Here we present a complementary covalent mechanism that is critical in vivo. We observed that camptothecins induce oxidative stress, leading to lipid peroxidation, lipid-derived electrophile accumulation, and Top1 poisoning via covalent modification. The electrophile 4-hydroxy-2-nonenal can induce Top1 on its own and forms a Michael adduct to a cysteine thiol in the Top1 active site, potentially blocking tyrosine dephosphorylation and 3' DNA phosphate release. Thereby, camptothecins may leverage a physiological cysteine-based redox switch in Top1 to mediate their selective toxicity to rapidly proliferating cancer cells.

摘要

拓扑异构酶 1(Top1)可逆地切开染色体 DNA,以松弛转录、复制、染色质组装和染色体浓缩过程中积累的张力。拓扑异构酶 1 抑制剂喜树碱通过将酶捕获在共价复合物 Top1 中,从而靶向癌细胞,由酪氨酸 3'-磷酸酯键将酶与断裂的 DNA 连接。体外机制研究指出,喜树碱与 Top1-DNA 界面的结合稳定了 Top1,从而产生界面抑制。在这里,我们提出了一种在体内至关重要的互补共价机制。我们观察到喜树碱会诱导氧化应激,导致脂质过氧化、脂质衍生的亲电物积累以及通过共价修饰导致 Top1 中毒。亲电物 4-羟基-2-壬烯醛本身可以诱导 Top1,并与 Top1 活性位点中的半胱氨酸巯基形成迈克尔加成物,可能阻止酪氨酸去磷酸化和 3' DNA 磷酸酯的释放。因此,喜树碱可能利用 Top1 中基于生理半胱氨酸的氧化还原开关来介导其对快速增殖的癌细胞的选择性毒性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecf2/8206239/454b97f98a1a/nihms-1658046-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecf2/8206239/e20692a177c8/nihms-1658046-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecf2/8206239/cad7cbd91024/nihms-1658046-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecf2/8206239/6b64956e9460/nihms-1658046-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecf2/8206239/04be3d56c0db/nihms-1658046-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecf2/8206239/5843a6cc3c69/nihms-1658046-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecf2/8206239/454b97f98a1a/nihms-1658046-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecf2/8206239/e20692a177c8/nihms-1658046-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecf2/8206239/cad7cbd91024/nihms-1658046-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecf2/8206239/6b64956e9460/nihms-1658046-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecf2/8206239/04be3d56c0db/nihms-1658046-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecf2/8206239/5843a6cc3c69/nihms-1658046-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecf2/8206239/454b97f98a1a/nihms-1658046-f0006.jpg